Additional Oxerutin Therapy to Promote Deep Vein Thrombus Resolution – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Stephanie Carlin et al, adding:
“Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.”
Title: Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study
Authors: Stephanie Carlin, Anne M. Holbrook, Matteo Candeloro, Francis Nguyen, Michael Paterson, James Douketis.
Read the Full Article on Journal of Thrombosis and Haemostasis.
Get the latest from Hemostasis Today.
-
Feb 6, 2026, 18:47Srishti Goyal: Blood Donation – The Health Benefits No One Talks About
-
Feb 6, 2026, 18:42Jim Hoffman: Targeting Extracorporeal Removal of Extracellular Chromatin to Mitigate Lupus Pathogenesis
-
Feb 6, 2026, 18:37Erwin Loh: High-Salt Diet Linked to Inflammation and Memory Loss by Altering the Microbiome
-
Feb 6, 2026, 18:31Tareq Abadl: Massive Transfusion Protocols – Speed, Balance, and Survival
-
Feb 6, 2026, 18:27Sarah-Jane Nkrumah: Giving a Wider Understanding to Those Living With Sickle Cell
-
Feb 6, 2026, 18:07Anna Kouraba: Laiko Hospital’s Contribution to rFVIII Single Chain Real-World Evidence at EAHAD 2026
-
Feb 6, 2026, 18:02Erik Berntorp and Kathelijn Fischer Honored with The EAHAD 2026 Lifetime Achievement Award
-
Feb 6, 2026, 17:34Raising Awareness of Factor I Deficiency – Hemophilia Welfare Society Karachi Pakistan
-
Feb 6, 2026, 17:29Alexis Guédon: Cardiovascular Risk Profiles and Outcomes in Patients With Giant Cell Arteritis